...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF trading

I put an order for 800 shares of ZHCLF, limit .60 and it filled at .59.  I already had 200 shares from the RVX spin-off acquired in 2013 , so I wanted to level it up to a thousand shares. I live in the USA using Fidelity.  

Share
New Message
Please login to post a reply